REFERENCES
- Bohmer T, Rynding A, Solberg HE: Carnitine levels in human serum in health and disease. Clin Chim Acta 57:55-61, 1974.
- Brooks H, Goldberg L, Holland R et al: Carnitine-induced effects on cardiac and peripheral hemodynamics. J Clin Pharmacol 17:561-578,1977.
- Christiansen R, Bremer J: Active transport of butyrobetaine and carnitine into isolated liver cells. Biochem Biophys Acta 448:562-577,1977.
- Lindstedt S, Lindstedt G: Distribution and excretion of carnitine14CO2 in the rat. Acta Chim Scand 15:701-702, 1961.
- Rebouche CJ, Engel AG: Carnitine metabolism and deficiency syndromes. Mayo Clin Proc 58: 533-540, 1983.
- Rebouche CJ, Paulson DJ: Carnitine metabolism and function in humans. Ann Rev Nutr 6:41-68, 1986.
- Scriver CR, Beaudet AL, Sly WS, Valle D: The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, 1989.
- Schaub J, Van Hoof F, Vis HL: Inborn Errors of Metabolism. Raven Press, New York, 1991.
- Marzo A, Arrigoni Martelli E, Mancinelli A, Cardace G, Corbelletta C, Bassani E, Solbiati M: Protein binding of L-carnitine family ccomponents Eur J Drug Met Pharmacokin, Special Issue III: 364-368,1992.
- Rebouche C: Quantitative estimation of absorption and degradation of a carnitine supplement by human adults. Metabolism: 1305-1310, 1991
Manufactured by: Manufactured for:
Ben Venue Laboratories, Inc Bedford Laboratories™
Bedford, OH 44146 Bedford, OH 44146
March 2004 Div-LVO-P02
|